Cargando…
Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021
IMPORTANCE: Advances in treatment of metastatic breast cancer (MBC) led to changes in clinical practice and treatment costs in the US over the past decade. There is limited information on current MBC treatment sequences and associated costs by MBC subtype in the US. OBJECTIVES: To identify treatment...
Autores principales: | Jaber Chehayeb, Rachel, Hood, Annette, Wang, Xiaoliang, Miksad, Rebecca, Schellhorn Mougalian, Sarah, Lustberg, Maryam B., Wang, Shi-Yi, Greenup, Rachel A., Pusztai, Lajos, Kunst, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709649/ https://www.ncbi.nlm.nih.gov/pubmed/36445704 http://dx.doi.org/10.1001/jamanetworkopen.2022.44204 |
Ejemplares similares
-
Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer
por: Kunst, Natalia, et al.
Publicado: (2020) -
Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy
por: Rozenblit, Mariya, et al.
Publicado: (2021) -
Challenges in Predicting Future Costs for Metastatic Breast Cancer
por: Dinan, Michaela A, et al.
Publicado: (2021) -
The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021
por: Goyal, Gaurav, et al.
Publicado: (2023) -
SH2 Domain Binding: Diverse FLVRs of Partnership
por: Jaber Chehayeb, Rachel, et al.
Publicado: (2020)